Market capitalization | $133.26m |
Enterprise Value | $-87.84m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | 1.73 |
EV/Sales (TTM) EV/Sales | -6.12 |
P/S ratio (TTM) P/S ratio | 9.29 |
P/B ratio (TTM) P/B ratio | 0.39 |
Revenue growth (TTM) Revenue growth | -10.78% |
Revenue (TTM) Revenue | $14.35m |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
3 Analysts have issued a Seer Inc - Ordinary Shares - Class A forecast:
3 Analysts have issued a Seer Inc - Ordinary Shares - Class A forecast:
Sep '24 |
+/-
%
|
||
Revenue | 14 14 |
11%
11%
|
|
Gross Profit | 2.20 2.20 |
6%
6%
|
|
EBITDA | -93 -93 |
8%
8%
|
EBIT (Operating Income) EBIT | -99 -99 |
7%
7%
|
Net Profit | -83 -83 |
9%
9%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Seer, Inc. (California) engages in the development of proprietary engineered nanoparticles to provide access across the proteome. Its Proteograph product suite comprises automation instrument and software, which provides workflow to make proteomic profiling. The company was founded by Philip Ma, Robert S. Langer Jr., and Omid C. Farokhzad on March 16, 2017 and is headquartered in Redwood City, CA.
Head office | United States |
CEO | Omid Farokhzad |
Employees | 147 |
Founded | 2017 |
Website | www.seer.bio |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.